PERNIX THERAPEUTICS HOLDINGS, INC.·4

Mar 28, 5:01 PM ET

PERNIX THERAPEUTICS HOLDINGS, INC. 4

4 · PERNIX THERAPEUTICS HOLDINGS, INC. · Filed Mar 28, 2014

Insider Transaction Report

Form 4
Period: 2014-03-26
Smith James Edward Jr.
Director10% Owner
Transactions
  • Sale

    Common Stock

    2014-03-26$5.52/sh15,000$82,7964,732,704 total
  • Sale

    Common Stock

    2014-03-28$5.42/sh15,000$81,2704,702,704 total
  • Sale

    Common Stock

    2014-03-27$5.46/sh15,000$81,9544,717,704 total
Holdings
  • Common Stock

    (indirect: By daughter)
    3,200
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/3/14.
  • [F2]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.29 to $5.78, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.78, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.27 to $5.54, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    issuerdirect_section16.xmlPrimary

    PRIMARY DOCUMENT